Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Gulati

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
Journal of the National Cancer Institute|February 14, 2019
Cancer Outcomes in DCIS Patients Without Locoregional TreatmentMarc D Ryser, Donald L Weaver, Fengmin Zhao, et al.
Annals of Internal Medicine|June 3, 2024
Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model AnalysisRoman Gulati, Boshen Jiao, Ra'ad Al-Faouri, et al.
International Journal of Cancer|July 16, 2025
Cost effectiveness analysis of prostate cancer screening strategies in Germany: A microsimulation studyMuchandifunga Trust Muchadeyi, Shuang Hao, Karla Hernandez-Villafuerte, et al.
European Urology|June 18, 2024
Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD TrialRuben Raychaudhuri, Makayla DeJong, Matthew Rettig, et al.
Cancer|April 25, 2017
Is prostate cancer different in black men? Answers from 3 natural history modelsAlex Tsodikov, Roman Gulati, Tiago M de Carvalho, et al.
Journal of the National Cancer Institute|May 10, 2025
Reduced adipose tissue with limited loss of lean mass after weight loss: results from the Prostate Active Lifestyle StudyJeannette M Schenk, Roman Gulati, Sarah J Beatty, et al.
Contemporary Clinical Trials|April 20, 2019
Randomized trial evaluating the role of weight loss in overweight and obese men with early stage prostate Cancer on active surveillance: Rationale and design of the Prostate Cancer Active Lifestyle Study (PALS)Jeannette M Schenk, Marian L Neuhouser, Sarah J Beatty, et al.
Plos One|November 9, 2013
Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodelingHolly M Nguyen, Nazanin Ruppender, Xiaotun Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2012
Prostate cancer mortality following active surveillance versus immediate radical prostatectomyJing Xia, Bruce J Trock, Matthew R Cooperberg, et al.
Journal of Medical Screening|February 10, 2021
Impact of cancer screening on metastasis: A prostate cancer case studyJane Lange, Sebastiaan Remmers, Roman Gulati, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Journal of the National Cancer Institute|February 14, 2019
Cancer Outcomes in DCIS Patients Without Locoregional TreatmentMarc D Ryser, Donald L Weaver, Fengmin Zhao, et al.
Annals of Internal Medicine|June 3, 2024
Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model AnalysisRoman Gulati, Boshen Jiao, Ra'ad Al-Faouri, et al.
International Journal of Cancer|July 16, 2025
Cost effectiveness analysis of prostate cancer screening strategies in Germany: A microsimulation studyMuchandifunga Trust Muchadeyi, Shuang Hao, Karla Hernandez-Villafuerte, et al.
European Urology|June 18, 2024
Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD TrialRuben Raychaudhuri, Makayla DeJong, Matthew Rettig, et al.
Cancer|April 25, 2017
Is prostate cancer different in black men? Answers from 3 natural history modelsAlex Tsodikov, Roman Gulati, Tiago M de Carvalho, et al.
Journal of the National Cancer Institute|May 10, 2025
Reduced adipose tissue with limited loss of lean mass after weight loss: results from the Prostate Active Lifestyle StudyJeannette M Schenk, Roman Gulati, Sarah J Beatty, et al.
Contemporary Clinical Trials|April 20, 2019
Randomized trial evaluating the role of weight loss in overweight and obese men with early stage prostate Cancer on active surveillance: Rationale and design of the Prostate Cancer Active Lifestyle Study (PALS)Jeannette M Schenk, Marian L Neuhouser, Sarah J Beatty, et al.
Plos One|November 9, 2013
Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodelingHolly M Nguyen, Nazanin Ruppender, Xiaotun Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2012
Prostate cancer mortality following active surveillance versus immediate radical prostatectomyJing Xia, Bruce J Trock, Matthew R Cooperberg, et al.
Journal of Medical Screening|February 10, 2021
Impact of cancer screening on metastasis: A prostate cancer case studyJane Lange, Sebastiaan Remmers, Roman Gulati, et al.
Pageof 16